EQT Mid Market Europe targets control or co-control investments in high-quality, medium-sized companies in Northern Europe (including the Nordics, DACH and the Benelux) with attractive value creation and growth potential. EQT Mid Market Europe seeks to make investments in companies with an enterprise value between EUR 100 million and EUR 300 million. The fund demonstrates EQT’s capability to combine the firm’s global multi-product platform and the “local with locals” approach with offices across the world and the specialist skills of EQT’s industrial network.
Commitments by region
Commitments by type
Portfolio
| Company | Sector | Country | Entry | Exit |
|---|---|---|---|---|
| TransIP | TMT | Netherlands | Aug 2016 | Sep 2017 |
| Fertin Pharma | Healthcare | Denmark | Jan 2017 | |
| Utimaco | TMT | Germany | Jan 2017 | |
| Adamo | TMT | Spain | Dec 2016 | |
| Open Systems | TMT | Switzerland | Jun 2017 | |
| Epidemic Sound | TMT | Sweden | Dec 2017 | |
| Dunlop | Industrial Technology | Netherlands | Jun 2018 | |
| Iver | TMT | Sweden | Apr 2018 | |
| BBS Automation | Industrial Technology | Germany | May 2018 | |
| IP-Only | TMT | Sweden | Jul 2013 | Jun 2019 |